Sanofi SNYNF
NASDAQ SNYNF
$90.01 +3.08 (+3.54%)
At close: Aug 18, 2026 · 4:00 PM EDT

Sanofi (SNYNF) Payables (2009 - 2026)

Sanofi (SNYNF) posted Payables of $8.3 billion for Q2 2026, down 3.01% sequentially from $8.6 billion in Q4 2025, and up 3.77% YoY from $8.0 billion in Q2 2025.

Sanofi (SNYNF) Payables (2009 - 2026) Analysis & Trends

Sanofi has reported Payables for 18 years, with the latest figure at $8.3 billion in Q2 2026.

  • Quarterly Payables rose 3.77% year-over-year to $8.3 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $8.3 billion (up 3.77% YoY) and the FY2025 annual result came in at $8.6 billion, up 6.19% from the prior year.
  • Payables declined to $8.3 billion in Q2 2026 per SNYNF's latest filing, from $8.6 billion in the prior quarter.
  • Over five years, Payables peaked at $8.6 billion in Q4 2025 and troughed at $7.0 billion in Q4 2022.
  • A 5-year average of $7.9 billion and a median of $8.0 billion in 2025 frame the typical range for Payables.
  • The sharpest annual moves came in 2022 and 2023: Payables declined 1.68% in 2022, then climbed 14.61% in 2023.
  • Over 5 years, Payables stood at $7.0 billion in 2022, then climbed by 13.43% to $7.9 billion in 2023, then advanced by 2.34% to $8.1 billion in 2024, then increased by 6.19% to $8.6 billion in 2025, then slipped by 3.01% to $8.3 billion in 2026.
  • According to Business Quant data, Payables over the past three periods registered $8.3 billion, $8.6 billion, and $8.0 billion for Q2 2026, Q4 2025, and Q2 2025 respectively.

Peer Comparison

Historic Data

Download Data
DateValue
Jun 30, 2026 8.31 Bn
Dec 31, 2025 8.57 Bn
Jun 30, 2025 8.01 Bn
Dec 31, 2024 8.07 Bn
Jun 30, 2024 8.00 Bn
Dec 31, 2023 7.88 Bn
Jun 30, 2023 8.02 Bn
Dec 31, 2022 6.95 Bn
Jun 30, 2022 7.00 Bn
Dec 31, 2021 7.07 Bn
Jun 30, 2021 6.47 Bn
Dec 31, 2020 6.31 Bn
Jun 30, 2020 5.42 Bn
Dec 31, 2019 133.27 Mn
Jun 30, 2019 5.71 Bn
Dec 31, 2018 5.75 Bn
Jun 30, 2018 69.22 Mn
Mar 31, 2018 5.32 Bn
Dec 31, 2017 5.46 Bn
Jun 30, 2017 4.73 Bn